GlassScriptPhysician profile
Holly B Hindman
NPI 1285770602
$19,904.23
in general payments reported to CMS, 2019-2025
17 companies · $7,219 in 2025
The $7,219 reported for 2025 was more than what 94% of Ophthalmology providers received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $46.26 · 2020: $19.40 · 2022: $2,975 · 2023: $653 · 2024: $8,992 · 2025: $7,219.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $7,600 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $4,800 · Travel and Lodging: $3,040 · Food and Beverage: $1,423.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $7,600.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $4,800.00 |
| Travel and Lodging | $3,040.34 |
| Food and Beverage | $1,423.23 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Carl Zeiss Meditec USA, INC. | $17,262.41 | 2022-2025 | Cirrus 6000 With Angioplex, Clarus, Cirrus Hd-Oct |
| Carl Zeiss Meditec, INC. | $1,377.90 | 2023-2025 | Cirrus Hd-Oct, Artevo 800, Lumera 700 |
| Alcon Vision LLC | $330.47 | 2022-2025 | Rocklatan, Wavelight Refractive Suite, Contoura Vision |
| Rxsight INC | $291.84 | 2023-2025 | Rxsight Injector Cartridge, Rxsight Contact Lens, Rxsight Light Delivery Device (Ldd) |
| Bausch & Lomb Americas INC. | $191.16 | 2022-2025 | Miebo, Xiidra, Victus |
| Horizon Therapeutics Plc | $147.74 | 2023 | Tepezza |
| Amgen INC. | $52.34 | 2024-2025 | Tepezza |
| Beaver-Visitec International, INC. | $37.31 | 2023 | |
| Abbvie INC. | $36.29 | 2025 | |
| Dompe US, INC. | $35.26 | 2024-2025 | Oxervate |
| Mallinckrodt Enterprises LLC | $33.76 | 2019 | |
| Mallinckrodt Hospital Products INC. | $24.31 | 2025 | Acthar |
| Ocular Therapeutix, INC. | $23.68 | 2025 | Dextenza |
| Carl Zeiss Meditec Ag | $19.40 | 2020 | |
| Sun Pharmaceutical Industries INC. | $13.94 | 2023 | Cequa |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Oyster Point Pharma, INC. | $13.92 | 2024 | Ryzumvi, Tyrvaya |
| Shire North American Group INC | $12.50 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Holly Hindman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.